ERICA LANG: Open Payments
NPI 1154916682 · MILLEDGEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 21 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $63 |
| Incyte Corporation | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
| Tempus AI, Inc | 1 | $30 |
| Agios Pharmaceuticals, Inc. | 1 | $28 |
| Kite Pharma, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
Products named: Nubeqa, ZEPZELCA, XT CDX, PYRUKYND, JAKAFI, Yescarta, ENHERTU, BLENREP.
Industry payments across GA — which companies pay providers there.
